Minireviews
Copyright ©The Author(s) 2021.
World J Transplant. Jul 18, 2021; 11(7): 290-302
Published online Jul 18, 2021. doi: 10.5500/wjt.v11.i7.290
Table 2 Outcomes of the main studies on extracorporeal membrane oxygenation as a bridge to lung transplantation
Ref.
Number of patients
Median duration of ECMO
Mode of ECMO
Complications
Successful bridge (%)
In-hospital mortality
1-yr survival
3-yr survival
Tipograf et al[31], 201912112 dVV (52%)ECMO site 11%59%9%88%83%
VA (43%)Renal 8.3%
VAV (2.5%)Vascular 12%
RA-LA (1.6%)Cardiac arrest 9.9%
PA-LA (0.8%)Cerebrovascular 12%
Biscotti et al[29], 20177212 dVV (62.5%)ECMO site 15.2%55.6%7.5%90.3%NR
VA (31.9%)Renal 8.3%
VAV (4.2%)Vascular 15.2%
PA-LA (1.4%)Cerebrovascular 5.5%
Hakim et al[32], 2018308 dVV (80%)Bleeding 33%87%NR85%80%
VA (16.7%)Cardiac arrest 13%
VVA (3.3%)Cannula fracture 3%
Thrombocytopenia 23%
Needing paralytics 27%
Benazzo et al[33], 20191205 dVV 34%Vascular 3.3%80%23.3%69%NR
VA 30%Cannula related 6.6%
iLA 21.7%IDC 0.8%
VAV 0.8%
Other 13.3%
Todd et al[27], 2017122 dVV 92%NR100%0%100%NR
VA 8%
Yeo et al[28], 20171917.5 dVV 79%Bleeding 26%73.7%42%57.9%NR
VA 16%Infections 10.5%
VAV 5%
Ko et al[30], 20202711 dVV 89%Bleeding 46.7%100%25.9%75%70%
VAV 7.4%Infections 26.7%
VA 3.7%Airway 13.3%
Hoetzenecker et al[34], 20187110 dVV 42.3%Cerebrovascular 4.2%88.7%NR70%63%
VA 9.9%Renal 31.7%
PA-LA 12.7%Bleeding 34.9%
Other 33.8%
Ius et al[35], 2018879 dVV 73%Bleeding 21%78%15%79%NR
VA 37%Renal 27%
Vascular 10%
Cerebrovascular 2%
Atrial fibrillation 13%